First, we have shown that in LN-229 and LN-308 glioblastoma cells, which are functionally wild-type and mutant for p53, respectively [16], the amount of DSB (γH2AX foci) increases as a linear function of dose. This evidence concerns the gene TP53 and glioblastoma.